← Leaderboards
Robert E Molokie
University Of Illinois At Chicago
$2,244,680
Attributed
$10,864,560
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,864,560 · 5
By mechanism
UH3$6,352,490 · 1
R01$3,239,886 · 1
UG3$827,226 · 1
R21$437,458 · 1
R13$7,500 · 1
Top collaborators
- Diana J Wilkie10 shared
- Zaijie Jim Wang7 shared
- Ardith Z Doorenbos5 shared
- Miriam Omelebele Ezenwa5 shared
- Judith Michelle Schlaeger5 shared
- Nirmish R Shah5 shared
- Mitchell Robert Knisely4 shared
- Nadine Matthie2 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Marian L Fitzgibbon$23,506,286
- Judith Michelle Schlaeger$4,439,333
- Lisa Tussing-Humphreys$6,306,920
- Zaijie Jim Wang$13,634,711
- Hongjin Li$1,115,484
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaPainChronic PainOpioidChronicSymptomsSiteProtocols DocumentationAfricanCharacteristicsResponseCaringBasePain ManagementFutureOpioid UseAdultAmericanPain ReductionAcuteInnovationInformation GatheringAreaDesign
Grant awards (12)
Exploring the Mediterranean Diet as A Promising Approach for Alleviating Chronic Pain in Sickle Cell Disease$437,458
R21 · FY2025 · AT
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,584,065
UH3 · FY2024 · AT
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,582,439
UH3 · FY2023 · AT
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,573,843
UH3 · FY2022 · AT
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,612,143
UH3 · FY2021 · AT
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$827,226
UG3 · FY2020 · AT
HL-Phenotypic Characterization of Chronic Pain in Adults with Sickle Cell Disease$823,373
R01 · FY2017 · HL · contact PI
HL-Phenotypic Characterization of Chronic Pain in Adults with Sickle Cell Disease$827,237
R01 · FY2016 · HL · contact PI
HL-Phenotypic Characterization of Chronic Pain in Adults with Sickle Cell Disease$779,804
R01 · FY2015 · HL · contact PI
HL-Phenotypic Characterization of Chronic Pain in Adults with Sickle Cell Disease$30,780
R01 · FY2015 · HL
HL-Phenotypic Characterization of Chronic Pain in Adults with Sickle Cell Disease$778,692
R01 · FY2014 · HL
Pain in Sickle Cell Disease: Basic & Clinical Science Advances and Future Directi$7,500
R13 · FY2011 · HL